Publicaties
- pdf
The Analytical Performance of Neonatal Total Bilirubin Assays Does Not Meet the Clinical Need
Oostendorp M, Van der Hagen EA, Lo S, Delatour V, Grote-Koska D, Staaden A, Frasa MA, Kootstra-Ros JE, Westenberg L, Vítek L, Dvořák A, Křepelka D, Weykamp C, Hulzebos CV, Van Berkel M. The Analytical Performance of Neonatal Total Bilirubin Assays Does Not Meet the Clinical Need. Clin Chem. 2026 Mar 5;72(3):419-421. doi: 10.1093/clinchem/hvaf175. PMID: 41385263. - Ozcan O, Heijboer AC, den Elzen WP. A survey of clinical laboratories in the Netherlands regarding pre-analytical conditions of renin measurements to prevent cryoactivation. Ann Clin Biochem. 2026 Mar 3:45632261433341. doi: 10.1177/00045632261433341. Epub ahead of print. PMID: 41773499.
- pdf
Laboratory solution to diagnose and monitor atypical IgG4-mediated anti-GBM disease
Jacobs JFM, Lambeck AJA, Lammerts RGM, van de Logt AE, Sanders JS, Lenssen M, Eijgelsheim M, Bajema I, Steenbergen EJ, Hoefsloot W, van der Meijden WAG, van der Molen RG. Laboratory solution to diagnose and monitor atypical IgG4-mediated anti-GBM disease. Clin Chem Lab Med. 2026 Feb 2;64(5):1102-1108. doi: 10.1515/cclm-2025-1499. PMID: 41620942. - pdf
Two-sample fecal immunochemical testing as a tool to avert
Moen S, Wisse PHA, Marijnissen F, Raab H, Lansdorp-Vogelaar I, Jansen JM, Tielemans MM, Leeuwenburgh I, Wolters LMM, Hol L, Ter Borg PCJ, Bekkering FC, Mulder S, Schot I, Frasa M, Thelen M, van Vuuren AJ, Spaander MCW. Two-sample fecal immunochemical testing as a tool to avert colonoscopy in symptomatic patients: a prospective multicenter cohort study. Endoscopy. 2026 Feb;58(2):174-183. doi: 10.1055/a-2650-0664. Epub 2025 Jul 6. PMID: 40618757; PMCID: PMC12829320. - pdf
Why Metrological Traceability Matters in Medical Laboratory Diagnostics
van Schrojenstein Lantman M, Cobbaert C, Panteghini M, van Berkel M, Smeets RL, van Hellemond JJ, Thelen MHM. Why Metrological Traceability Matters in Medical Laboratory Diagnostics. J Appl Lab Med. 2026 Jan 23:jfaf203. doi: 10.1093/jalm/jfaf203. Epub ahead of print. PMID: 41575756. - pdf
Science, Quality and Value of Laboratory Medicine
Plebani M, Langlois M, von Meyer A, Vermeersch P, Zaninotto M, Smeets RL, Padoan A, Çubukçu HC, Monaghan P, Coşkun A, Orth M, Thelen M. Science, Quality and Value of Laboratory Medicine. Clin Chem Lab Med. 2026 Jan 22. doi: 10.1515/cclm-2026-0041. Epub ahead of print. PMID: 41565613. - pdf
Evaluation of Total Bilirubin in a National Quality Program
Westenberg LEH, Lantman MVS, van Berkel M, Thelen MHM, Tintu A, Vis JY, Weykamp CW, Oostendorp M, Frasa M, Kootstra-Ros JE, van der Hagen E, Schoenmakers CHH, Schenk PW, Been JV, Hulzebos CV. Evaluation of Total Bilirubin in a National Quality Program. Clin Chem. 2025 Dec 30;72(1):183-191. doi: 10.1093/clinchem/hvaf144. PMID: 41468129. - pdf
Influence of ultrafiltration conditions on the unbound fraction of phenytoin and valproic acid
Temme PP, van Luin M, Deenen MJ, Meijer R, Jager NGL, Malingré MM. Influence of ultrafiltration conditions on the unbound fraction of phenytoin and valproic acid. Eur J Clin Pharmacol. 2025 Sep 9. doi: 10.1007/s00228-025-03918-3. Epub ahead of print. PMID: 40924145. - pdf
Response to the editorial by Karl Lackner
van Schrojenstein Lantman M, Thelen M. Response to the editorial by Karl Lackner. Clin Chem Lab Med. 2025 Jul 30;63(12):e258-e260. doi: 10.1515/cclm-2025-0334. PMID: 40735776. - pdf
Two-sample fecal immunochemical testing as a tool to avert colonoscopy in symptomatic patients a prospective multicenter cohort study
Moen S, Wisse PHA, Marijnissen F, Raab H, Lansdorp-Vogelaar I, Jansen JM, Tielemans MM, Leeuwenburgh I, Wolters LMM, Hol L, Ter Borg PCJ, Bekkering FC, Mulder S, Schot I, Frasa M, Thelen M, van Vuuren AJ, Spaander MCW. Two-sample fecal immunochemical testing as a tool to avert colonoscopy in symptomatic patients: a prospective multicenter cohort study. Endoscopy. 2026 Feb;58(2):174-183. doi: 10.1055/a-2650-0664. Epub 2025 Jul 6. PMID: 40618757; PMCID: PMC12829320.
2026
2025